Inventor · disambiguated record
Pieter Smid
Also filed as: SMID PIETER
6 granted patents·4 pending applications·10 citations·filing 2005–2015
74Inventor score
Top patents by PatentIndex Score
10 records- 0177US8796262B2Fused heterocyclic derivatives as S1P modulatorsSMID PIETER·Filed 2011·Granted Aug 5, 2014·5 cites·31 claims
- 0276US9670220B2Fused heterocyclic derivatives as S1P modulatorsABBVIE BV·Filed 2015·Granted Jun 6, 2017·2 cites·24 claims
- 0373US9096612B2Fused heterocyclic derivatives as S1P modulatorsABBVIE BV·Filed 2013·Granted Aug 4, 2015·2 cites·22 claims
- 0470US7371769B2Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sitesSOLVAY PHARM BV·Filed 2005·Granted May 13, 2008·1 cites·18 claims
- 0546US2008146524A1Selective inhibitors of neurotensin degrading enzymesSOLVAY PHARM BV·Filed 2007·Application pending·0 cites
- 0644US8575148B2Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockersSMID PIETER·Filed 2009·Granted Nov 5, 2013·0 cites·14 claims
- 0744US2007219214A1Dual NK2/NK3-antagonists, pharmaceutical compositions comprising them, and processes for their preparationSOLVAY PHARM GMBH·Filed 2007·Application pending·0 cites
- 0840US2006122177A1Phenylpiperazines with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sitesSOLVAY PHARM BV·Filed 2005·Application pending·0 cites
- 0940US2006122175A1Benzdioxane piperazine derivatives with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sitesSOLVAY PHARM BV·Filed 2005·Application pending·0 cites
- 1039USRE48301EFused heterocyclic derivatives as S1P modulatorsABBVIE BV·Filed 2011·Granted Nov 10, 2020·0 cites·39 claims
Join the waitlist — get patent alerts
Get an alert when Pieter Smid files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →